RecruitingNot ApplicableNCT03787745

Ischemic Postconditioning in STEMI Patients Treated With Primary PCI

The Effect of Ischemic Postconditioning in Patients With STEMI Undergoing Primary PCI (DANAMI4-iPOST2)

Sponsor

Rigshospitalet, Denmark

Enrollment

1,800 participants

Start Date

Feb 4, 2019

Study Type

INTERVENTIONAL

Conditions

ST Segment Elevation Myocardial Infarction

Summary

In a prospective, randomized clinical trial the iPOST2 trial will determine whether ischemic postconditioning reduces reperfusion injury and this will translate into improved clinical outcome of heart failure and death for STEMI patients who present with TIMI0-1 undergoing primary PCI

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Conventional and a procedure called Ischemic postconditioning for people with st segment elevation myocardial infarction. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREIschemic postconditioning

After 60 seconds of reperfusion, ischemic postconditioning with an adequately sized balloon (60 reperfusion/60 seconds re-occlusion, four cycles) will be performed

PROCEDUREConventional

State of the art primary PCI, however thrombectomy is not allowed